Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Sullivan

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
British Journal of Hospital Medicine|April 8, 1999
Are we winning the battle against the human immunodeficiency virusA K Sullivan, M R Nelson
International Journal of STD & AIDS|February 1, 1997
Allergic skin reaction to GCSF in a patient with AIDSA K Sullivan, M R Nelson
Journal of Cellular Biochemistry|June 1, 1988
Changes in glycoprotein fucosylation in a concanavalin A-resistant variant of a human leukemia cell line (K562)L G Bernier, A K Sullivan
Progress in Clinical and Biological Research|January 1, 1988
Inhibition of platelet aggregation by a monoclonal antibody to a pan-myeloid antigen (D-51)R Gareau, J Gruda, A K Sullivan
Leukemia Research|January 1, 1985
An antigen related to the phenotype of multi-drug resistance can be induced in vivo and used as a target for immunotherapy of rat leukemiaA Brox, G Price, A K Sullivan
Leukemia Research|January 1, 1984
Blastic variants of rat promyelocytic leukemia produce neurologic diseaseA Brox, S Glynn, A K Sullivan
International Journal of STD & AIDS|March 28, 1998
An audit of emergency contraception: a look at patient characteristics and the effects of a consultation proformaH Nanthakumaran, A K Sullivan, F C Boag
Cellular Immunology|February 15, 1983
Target cell specificity of human natural killer (NK) cells. I. Development of an NK-resistant subline of K562S L MacDougall, C Shustik, A K Sullivan
Cellular Immunology|December 1, 1986
Target cell specificity of human natural killer cells. II. Apparent change with activationS L MacDougall, C Shustik, A K Sullivan
Nature|July 21, 1977
Ia antigen expression on human epidermal Langerhans cellsG Rowden, M G Lewis, A K Sullivan
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
British Journal of Hospital Medicine|April 8, 1999
Are we winning the battle against the human immunodeficiency virusA K Sullivan, M R Nelson
International Journal of STD & AIDS|February 1, 1997
Allergic skin reaction to GCSF in a patient with AIDSA K Sullivan, M R Nelson
Journal of Cellular Biochemistry|June 1, 1988
Changes in glycoprotein fucosylation in a concanavalin A-resistant variant of a human leukemia cell line (K562)L G Bernier, A K Sullivan
Progress in Clinical and Biological Research|January 1, 1988
Inhibition of platelet aggregation by a monoclonal antibody to a pan-myeloid antigen (D-51)R Gareau, J Gruda, A K Sullivan
Leukemia Research|January 1, 1985
An antigen related to the phenotype of multi-drug resistance can be induced in vivo and used as a target for immunotherapy of rat leukemiaA Brox, G Price, A K Sullivan
Leukemia Research|January 1, 1984
Blastic variants of rat promyelocytic leukemia produce neurologic diseaseA Brox, S Glynn, A K Sullivan
International Journal of STD & AIDS|March 28, 1998
An audit of emergency contraception: a look at patient characteristics and the effects of a consultation proformaH Nanthakumaran, A K Sullivan, F C Boag
Cellular Immunology|February 15, 1983
Target cell specificity of human natural killer (NK) cells. I. Development of an NK-resistant subline of K562S L MacDougall, C Shustik, A K Sullivan
Cellular Immunology|December 1, 1986
Target cell specificity of human natural killer cells. II. Apparent change with activationS L MacDougall, C Shustik, A K Sullivan
Nature|July 21, 1977
Ia antigen expression on human epidermal Langerhans cellsG Rowden, M G Lewis, A K Sullivan
Pageof 10